Episode

From ASH 2025 to the Clinic: Global Perspectives on Evolving BTK Therapies in Relapsed/Refractory CLL

Podcast
Decera Clinical Education Oncology Podcast
Published
Mar 11, 2026
Duration seconds
1824
Processing state
not_requested
Canonical source
https://oncologypodcast.simplecast.com/episodes/from-ash-2025-to-the-clinic-global-perspectives-on-evolving-btk-therapies-in-relapsed-refractory-cll-dk0fFFb5
Audio
https://afp-928689-injected.calisto.simplecastaudio.com/1d8e143b-904e-45be-b6c5-8fba793d9d74/episodes/8a9db931-2a92-41df-b0b3-398ca8b7dcaa/audio/128/default.mp3?aid=rss_feed&awCollectionId=1d8e143b-904e-45be-b6c5-8fba793d9d74&awEpisodeId=8a9db931-2a92-41df-b0b3-398ca8b7dcaa&feed=GlfUTtJq
JSON
/v1/public/podcasts/decera-clinical-education-oncology-podcast-1302999/episodes/from-ash-2025-to-the-clinic-global-perspectives-on-evolving-btk-therapies-in-relapsed-refractory-cll
Markdown
/podcast/decera-clinical-education-oncology-podcast-1302999/from-ash-2025-to-the-clinic-global-perspectives-on-evolving-btk-therapies-in-relapsed-refractory-cll.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/decera-clinical-education-oncology-podcast-1302999/episodes/from-ash-2025-to-the-clinic-global-perspectives-on-evolving-btk-therapies-in-relapsed-refractory-cll/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999/from-ash-2025-to-the-clinic-global-perspectives-on-evolving-btk-therapies-in-relapsed-refractory-cll.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

This episode features Matthew S. Davids, MD, MMSc; Nelson Hamerschlak, MD, PhD; and Stephen Stilgenbauer, MD, discussing key conference highlights from the 2025 ASH Annual Meeting, with a focus on emerging BTK-targeted therapies in relapsed/refractory CLL. They share global perspectives on real-world use, sequencing strategies, safety considerations, and how new data may shape future clinical practice.